{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:29:43Z","timestamp":1792808983510,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejogrb.2022.06.029","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T11:11:14Z","timestamp":1656760274000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up"],"prefix":"10.1016","volume":"276","author":[{"given":"Jarbas","family":"Magalhaes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson Santos","family":"Ferreira-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Soares-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2001-18643","article-title":"Progestin-releasing intrauterine systems","volume":"19","author":"Luukkainen","year":"2001","journal-title":"Sem Reprod Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Kaunitz","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6 SUPPL.","key":"10.1016\/j.ejogrb.2022.06.029_b0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.contraception.2007.01.008","article-title":"Treatment of menorrhagia with an LNG-IUS","volume":"75","author":"Pakarinen","year":"2007","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijgo.2013.05.018","article-title":"Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding","volume":"123","author":"Cihangir","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.06.029_b0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2010.05.005","article-title":"Non-contraceptive health benefits of intrauterine hormonal systems","volume":"82","author":"Fraser","year":"2010","journal-title":"Contraception"},{"issue":"6 SUPPL.","key":"10.1016\/j.ejogrb.2022.06.029_b0030","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.contraception.2006.12.013","article-title":"The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease","volume":"75","author":"Fraser","year":"2007","journal-title":"Contraception"},{"issue":"18","key":"10.1016\/j.ejogrb.2022.06.029_b0035","first-page":"1","article-title":"Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: a health technology assessment","volume":"16","author":"Health Quality Ontario","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2012.08.022","article-title":"Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: A pooled analysis of randomized controlled studies","volume":"87","author":"Jensen","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.contraception.2011.12.005","article-title":"Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil","volume":"86","author":"Bahamondes","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: A randomized clinical trial","volume":"83","author":"Shabaan","year":"2011","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijgo.12887","article-title":"Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system","volume":"146","author":"Li","year":"2019","journal-title":"Int J Gynecol Obstetrics"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0065","article-title":"Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri)","volume":"30","author":"Tosun","year":"2014","journal-title":"Pakistan J Med Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Magalh\u00e3es","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0075","first-page":"749","article-title":"Impact of fibroids on reproductive function","volume":"22","author":"Khaund","year":"2008","journal-title":"Best Practice Res: Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.06.029_b0080","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorieva","year":"2003","journal-title":"Fertil Steril"},{"issue":"6 SUPPL.","key":"10.1016\/j.ejogrb.2022.06.029_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2007.01.012","article-title":"Progestin-releasing intrauterine systems and leiomyoma","volume":"75","author":"Kaunitz","year":"2007","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.ejogrb.2022.06.029_b0090","first-page":"2255","article-title":"Comparative effectiveness and impact on health-related quality of life of hysterectomy vs. levonorgestrel intra-uterine system for abnormal uterine bleeding","volume":"21","author":"Cozza","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.06.029_b0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/09513590.2013.769517","article-title":"The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids","volume":"29","author":"Machado","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2022.06.029_b0100","doi-asserted-by":"crossref","first-page":"e2063","DOI":"10.6061\/clinics\/2020\/e2063","article-title":"Gynecology and women's health care during the COVID-19 pandemic: Patient safety in surgery and prevention","volume":"75","author":"Soares-J\u00fanior","year":"2020","journal-title":"Clinics"},{"issue":"12","key":"10.1016\/j.ejogrb.2022.06.029_b0105","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.06.029_b0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17512433.2020.1782738","article-title":"Contraception and reproductive planning during the COVID-19 pandemic","volume":"13","author":"Ferreira-Filho","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2022.06.029_b0115","doi-asserted-by":"crossref","unstructured":"The American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013 Apr;121(4):891\u20136.","DOI":"10.1097\/01.AOG.0000428646.67925.9a"},{"key":"10.1016\/j.ejogrb.2022.06.029_b0120","unstructured":"World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Geneva; 2015."},{"issue":"7","key":"10.1016\/j.ejogrb.2022.06.029_b0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jcu.20049","article-title":"Value of sonography in the diagnosis of abnormal vaginal bleeding","volume":"32","author":"Dubinsky","year":"2004","journal-title":"J Clin Ultrasound"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2022.06.029_b0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracep Reproductive Health Care"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/aogs.14097","article-title":"Intrauterine device use is safe among nulligravidas and adolescent girls","volume":"100","author":"Bahamondes","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00404-008-0871-5","article-title":"Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: Effects on ovarian function and uterus","volume":"280","author":"Tasci","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0150","doi-asserted-by":"crossref","first-page":"S888","DOI":"10.1016\/j.ajog.2019.11.1288","article-title":"Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding","volume":"222","author":"Chen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shaaban","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"issue":"5\u20136","key":"10.1016\/j.ejogrb.2022.06.029_b0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0028-2243(86)90124-3","article-title":"The alkaline hematin method for measuring menstrual blood loss\u2013a modification and its clinical use in menorrhagia","volume":"22","author":"van Eijkeren","year":"1986","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fertnstert.2013.09.038","article-title":"Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study","volume":"101","author":"Brucker","year":"2014","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/GCO.0000000000000371","article-title":"New paradigms in the conservative surgical and interventional management of adenomyosis","volume":"29","author":"Alvi","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jmig.2015.09.018","article-title":"Adenomyosis: a clinical review of a challenging gynecologic condition","volume":"23","author":"Struble","year":"2016","journal-title":"J Minimally Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2008.11.004","article-title":"The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis","volume":"79","author":"Sheng","year":"2009","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.06.029_b0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","volume":"198","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2007.05.091","article-title":"Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging","volume":"76","author":"Bragheto","year":"2007","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.ejogrb.2022.06.029_b0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.6061\/clinics\/2017(10)08","article-title":"Review of magnetic resonance-guided focused ultrasound in the treatment of uterine fibroids","volume":"72","author":"Peregrino","year":"2017","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"10.1016\/j.ejogrb.2022.06.029_b0205","doi-asserted-by":"crossref","unstructured":"Sangkomkamhang US, Lumbiganon P, Pattanittum P. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy). Cochrane Database Syst Rev. 2020 Nov;11:CD008994.","DOI":"10.1002\/14651858.CD008994.pub3"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J Obstetrics Gynaecol Canada: JOGC"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.06.029_b0215","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000002942","article-title":"Ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"132","author":"Liu","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.06.029_b0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/AOG.0000000000003869","article-title":"Elagolix treatment for up to 12 months in women with heavy menstrual bleeding and uterine leiomyomas","volume":"135","author":"Simon","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2022.06.029_b0225","first-page":"613","article-title":"Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas","volume":"50","author":"Rosa e Silva","year":"2005","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijgo.2014.02.017","article-title":"Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system","volume":"126","author":"Youm","year":"2014","journal-title":"Int J Gynaecol Obstetrics"},{"issue":"10\u201313","key":"10.1016\/j.ejogrb.2022.06.029_b0235","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.steroids.2003.08.017","article-title":"Effects of progesterone on growth factor expression in human uterine leiomyoma","volume":"68","author":"Maruo","year":"2003","journal-title":"Steroids"},{"issue":"10\u201311","key":"10.1016\/j.ejogrb.2022.06.029_b0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2020.09.005","article-title":"Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta\u00ae) discontinuation","volume":"103","author":"Carr","year":"2021","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.06.029_b0250","first-page":"123","article-title":"Return of fertility in various types of IUD users","volume":"34","author":"Gupta","year":"1989","journal-title":"Int J Fertil"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.06.029_b0255","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0010-7824(92)90122-A","article-title":"Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T","volume":"46","author":"Andersson","year":"1992","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.06.029_b0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10815-019-01624-5","article-title":"Levonorgestrel IUD: is there a long-lasting effect on return to fertility?","volume":"37","author":"Dinehart","year":"2020","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.06.029_b0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.contraception.2018.05.009","article-title":"A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement","volume":"98","author":"Bahamondes","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2022.06.029_b0270","doi-asserted-by":"crossref","unstructured":"Modesto W, de Nazar\u00e9 Silva dos Santos P, Correia VM, Borges L, Bahamondes L. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use. Eur J Contracept Reproductive Health Care. 2015;20(1):57\u201363.","DOI":"10.3109\/13625187.2014.951433"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:57:14Z","timestamp":1759557434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522004122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":54,"alternative-id":["S0301211522004122"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.06.029","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}